Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05419713 · ClinicalTrials.gov registry record · NA
Intermediate Visual Space Perception
A NA study of Vision, sponsored by University of Louisville.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05419713: Recruiting NA study of Vision, sponsored by University of Louisville.
NCT05419713 is a NA study of Vision that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 180 participants, below the 2,058-participant average among 5 other Vision trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05419713, a NA study of Vision, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perception involved in judging distance, the focus of this project, in the planning and/or execution of self-motion in the natural 3D environment. The theoretical knowledge to be gained from this project will contribute to the scientific literature and provide insights into how eye and neurological defects could impair visual space perception, wayfinding, and mobility.
Primary Outcome
Subjects will judge perceived distances (cm) of test targets from themselves before self-motion to establish a baseline measure. Subjects will then undergo self-motion for an average of 10 sec, and stop at a predetermined location. Then subjects will again judge the perceived distance (cm) of test targets after the self-motion. The change in perceived distance (cm) from baseline will reveal if their perception is affected by environmental factors, internal perceptual process and/or cognitive pro
Conditions Studied
Interventions
- OTHER Visual Stimuli for Space Perception
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-09-30 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What NCT05419713 shows while recruiting
NCT05419713 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 2,058-participant average among 5 other Vision trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Vision appearing as the primary indexed condition, and to 1 intervention - of which Visual Stimuli for Space Perception is the first listed.
NCT05419713 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05419713 about?
NCT05419713 is a clinical study titled "Intermediate Visual Space Perception". The ability to judge the locations of various objects from oneself during self-motion in the intermediate distance range (\~2-25m) is crucial for successful performance of activities of daily living, such as walking and driving. However, little is known about the mechanisms of visual space perceptio...
What is the current status of trial NCT05419713?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-09-30. Estimated completion is 2025-06-30.
What conditions does trial NCT05419713 study?
This clinical trial studies the following conditions: Vision.
What interventions are being tested in trial NCT05419713?
The interventions under investigation include: Visual Stimuli for Space Perception (OTHER).
Who is sponsoring clinical trial NCT05419713?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05419713 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vision
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
RECRUITING · NA
-
Experiment 2: One Target in Many Situations
RECRUITING · NA
-
Mixed Vs Blocked Search: Four Unique Tasks
RECRUITING · NA
-
Experiment 3: Mixed vs Blocked; Dashboard Paradigm
RECRUITING · NA
-
Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI